Drug developer Pharmaxis has announced that the company’s medication for cystic fibrosis, Bronchitol, was included in the shortlist for…
Articles by Patrícia Silva, PhD
In the wake of positive news about new combination therapies involving the Vertex drug…
Half of the adults who suffer from cystic fibrosis (CF) are infected with the aspergillus fungus, according to medical…
A drug derived from Norwegian seaweed may help increase the life expectancy of people with cystic fibrosis,…
Bernstein Research analyst Geoff Porges advised investors about the probability of failure of the Vertex Pharmaceuticals’ experimental cystic fibrosis…
Clinical-stage biotech company Galapagos, which is based in Belgium, has announced positive results of a Phase II clinical trial for…
Last Wednesday, the 37th European Cystic Fibrosis Conference gathered leading CF caregivers and researchers in Gothenburg,…
Young people who suffer from physical disabilities or illnesses, such as cystic fibrosis, don’t always receive all of the…
For the 27th year, Cystic Fibrosis Research Inc. will hold a national conference to raise awareness of the disease and…
People with cystic fibrosis can be prone to developing diabetes. However, only recently have researchers learned that the onset…